Detection of novel biomarkers in patients with interstitial pneumonia or acute exacerbation of interstitial pneumonia.
Not Applicable
Recruiting
- Conditions
- Patients with interstitial pneumonias or acute exacerbation of interstitial pneumonias
- Registration Number
- JPRN-UMIN000044825
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with severe heart failure or excessive fluid overload were excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Diagnostic capacity, percent predicted forced vital capacity (%FVC) and diffusion lung capacity for carbon monoxide (%DLCO), the partial pressure of arterial oxygen (PaO2) at rest and minimum partial oxygen saturation during the 6-min walk test (6MWT), serum KL-6/SP-D, HRCT findings, findings on lung specimens, response to treatments